Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer

Matsumoto, A; Jinno, H; Naruse, S; Isono, Y; Maeda, Y; Sato, A; Yamada, M; Ikeda, T; Sasajima, Y

Jinno, H (通讯作者),Teikyo Univ, Dept Surg, Sch Med, 2-11-1Kaga, Tokyo, Tokyo 1738606, Japan.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (12): 1119

Abstract

Objective Dose-dense chemotherapy has shown a better prognosis than standard interval chemotherapy in adjuvant settings for high-risk breast cancer. T......

Full Text Link